Trial intelligence / Profile preview

Effect of Testofen on Erectile Function in an Adult Male Population

NCT05232279Phase 3Completed

Sponsor
RDC Clinical
Start
Apr 2022
Primary completion
Jul 2026
Modality
Dietary Supplement
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in erectile dysfunction (ED) (3 arms), sponsored by RDC Clinical. Primary endpoints: International Index of Erectile Function at 12 weeks and Erection Hardness Score at 12 weeks. Started Apr 2022; status: completed.

02

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT05232279.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05232279.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call